Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation.
Limited quarterly history available
EPS needs at least three reported quarters before a meaningful chart is shown.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-87.94
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Parabilis Medicines, Inc.
Market Cap
$3.36B
Earnings Per Share (EPS)
N/A
TTM Avg
-87.94
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.38B
Earnings Per Share (EPS)
2.22
TTM Avg
1.84
3Y Avg
0.49
5Y Avg
-0.14
Market Cap
$3.31B
Earnings Per Share (EPS)
-4.66
TTM Avg
-2.10
3Y Avg
-1.50
5Y Avg
-1.20
Market Cap
$3.44B
Earnings Per Share (EPS)
-1.17
TTM Avg
-1.00
3Y Avg
-1.15
5Y Avg
-1.50
Market Cap
$3.47B
Earnings Per Share (EPS)
-4.29
TTM Avg
-3.30
3Y Avg
-2.99
5Y Avg
-2.52
Market Cap
$3.48B
Earnings Per Share (EPS)
-1.94
TTM Avg
-2.32
3Y Avg
-2.00
5Y Avg
-1.79
Market Cap
$3.52B
Earnings Per Share (EPS)
-0.43
TTM Avg
-2.51
3Y Avg
-3.24
5Y Avg
-3.00
Market Cap
$3.54B
Earnings Per Share (EPS)
-4.74
TTM Avg
-3.69
3Y Avg
-3.04
5Y Avg
-2.46
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | $3.36B | N/A | -87.94 | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 2.22 | 1.84 | 0.49 | -0.14 |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | -4.66 | -2.10 | -1.50 | -1.20 |
| CareDx, Inc (CDNA)vs › | $3.30B | 2.07 | 0.30 | -1.10 | -0.90 |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | -1.17 | -1.00 | -1.15 | -1.50 |
| Celcuity Inc. (CELC)vs › | $3.47B | -4.29 | -3.30 | -2.99 | -2.52 |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | -1.94 | -2.32 | -2.00 | -1.79 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | -0.43 | -2.51 | -3.24 | -3.00 |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | -4.74 | -3.69 | -3.04 | -2.46 |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | -1.09 | -2.33 | -2.95 | -2.30 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-2.05
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -92.40 |
| 2024-12-31 | -83.48 |
